Merck
Codexis and Merck develop green Victrelis production
April 10, 2012Manufacturing and Production Codexis, Merck, manufacturing
Merck has teamed up with catalyst specialist Codexis to develop a more efficient manufacturing process for recently-approved hepatitis C treatment …
Victoza superiority to Januvia made official by FDA
April 10, 2012Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes
Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …
Merck appoints new chief ethics and compliance officer
March 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck
Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …
Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud
March 29, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines
Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors. Mahmoud, a global infectious …
Sanofi sets up cholesterol drug showdown with Amgen
March 27, 2012Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi
Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other. Both drugs …
Merck ends development on atrial fibrillation pill
March 20, 2012Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation
Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …
Merck warned over missing Januvia safety study
March 13, 2012Research and Development FDA, Januvia, Merck, study
Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …
inVentiv appoints former Quintiles man Mark Archer
March 9, 2012Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv
Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …
NICE recommends Victrelis in speedy review
March 9, 2012Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis
NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review. In its final …
Merck’s eye drug Zioptan gains FDA approval
February 14, 2012Sales and Marketing Merck, Pfizer, Xalatan, Zioptan
The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …
Fate of Merck’s vorapaxar still unclear
February 8, 2012Medical Communications, Sales and Marketing Merck, vorapaxar
Merck & Co’s blood thinner vorapaxar, designed to prevent blood clots and reduce heart attacks, is still causing bleeding in …
Merck prepares insomnia candidate
February 7, 2012Sales and Marketing Merck, insomnia
Merck is to file its new insomnia drug suvorexant, with US regulators later this year. Suvorexant is an orexin receptor …
Merck posts strong results for 2011
February 2, 2012Sales and Marketing Frazier, Merck, Singulair, Victrelis
Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011. The US firm …
Merck pays $37m to settle Canadian Vioxx claims
January 23, 2012Sales and Marketing Canada, Merck, Vioxx
Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada. The settlement …
Merck facility reborn as science park
January 11, 2012Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland
A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
